From concept to mobility
Providing technology- and value-driven solutions
View more
No data
Research products are for research use only.
Hepatitis E Virus RNA Detection Kit (FQ-PCR Method)
Hepatitis E virus (HEV) is a common pathogen worldwide that causes both acute and chronic viral hepatitis, primarily transmitted via the fecal–oral route and associated with related clinical manifestations. China is a high‑incidence area for hepatitis E, with an overall prevalence of 7.2%, and infection rates are higher in rural than in urban settings. The “Expert Consensus on In‑Hospital Screening and Management Procedures for Hepatitis E in China (2023 Edition)” states: “Hepatitis E test reports must clearly present results for anti‑HEV antibodies and HEV RNA. For cases positive for HVE‑IgM, it is recommended to perform additional testing for HEV RNA; all eligible individuals should be screened, and any positive results must be promptly reported to the hospital’s medical affairs department.”
This product performs qualitative detection of RNA in the serum of patients infected with hepatitis E virus, addressing the challenge of early diagnosis and providing reliable diagnostic results to enable timely diagnosis and treatment.
Follow us
Phone: 400-650-6787 | 010-67878866 | Address: Building 1, No. 7 Yuncheng Street, Beijing Economic-Technological Development Area, Beijing |
© 2026 Beijing Jinhao Pharmaceutical Co., Ltd. All rights reserved | Beijing ICP Filing No. 17020135-2